Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blinded, Phase IIb/III, Decentralized Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Participants With Mild to Moderate Acne Vulgaris

NCT02832063 is registered in ClinicalTrials.gov with AOBiome LLC as lead sponsor.

NCT NCT02832063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02832063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blinded, Phase IIb/III, Decentralized Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Participants With Mild to Moderate Acne Vulgaris
Lead sponsor
AOBiome LLC
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2016
Completion date
July 19, 2017
Enrollment
372 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris